Relapse of stage I small cell lung cancer ten or more years after the start of treatment

Japanese Journal of Clinical Oncology

Volumn 36, Issue 7, 2006, Pages 457-461

  Matsui, Kaoru ^a   Sawa, Toshiyuki ^a,b   Suzuki, Hidekazu ^a   Nakagawa, Katsuhiro ^a   Okamoto, Norio ^a   Tada, Takuhito ^c   Nagano, Teruaki ^a   Masuda, Noriyuki ^d  

^a OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^b Gifu Municipal Hospital   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

10 year disease free survival; Late relapse; Second malignancy; Small cell lung cancer

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IRINOTECAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; DRUG DOSE REGIMEN; FIBEROPTIC BRONCHOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LUNG FUNCTION TEST; LUNG RESECTION; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; SECOND CANCER; SURVIVAL TIME; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY;

EID: 33748097317     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl044     Document Type: Article

References (20)

1. Aisner J, Alberto P, Bitran J, Comis R, Daniels J, Hansen H, et al. Role of chemotherapy in small cell lung cancer: A consensus report of the international association for the study of lung cancer workshop. Cancer Treat Rep 1983;67:37-43.
2. Ohe Y. Chemoradiotherapy for lung cancer. Current status and perspectives. Int J Clin Oncol 2004;9:435-43.
3. Fukuoka M, Masuda N, Matsui K, Takada M, Negoro S, Kusunoki Y, et al. Three year disease-free survivors of small cell lung cancer treated with combination chemotherapy with or without chest irradiation. Eur J Cancer Clin Oncol 1989;25:331-6.
4. Fukuoka M, Masuda N, Matsui K, Makise Y, Takada M, Negoro S, et al. Combination Chemotherapy with or without radiation therapy in small cell lung cancer. An analysis of a five-year follow-up. Cancer 1990;65: 1678-84.
5. Jacoulet P, Depierre A, Moro D, Riviere A, Milleron B, Quoix E, et al. Long-term survivors of small-cell lung cancer (SCLC): A Frenchi multicenter study. Ann Oncol 1997;8:1009-14.
6. Vogelsang GB, Abeloff MD, Ettinger DS, Booker SV. Long-term survivors of small cell carcinoma of the lung. Am J Med 1985;79:49-56.
7. Masuda N, Fukuoka M, Takada M, Negoro S, Matsui K, Takifuji N, et al. Redevelopment of small-cell lung cancer nine years after the start of therapy. A case report and review of literature. Am J Clin Oncol 1991;14:322-7.
8. Jacobs RH, Greenburg A, Bitran JD, Hoffman PC, Albain KS, Desser R, et al. A ten-year experience with combined modality therapy for stage III small cell lung carcinoma. Cancer 1986;58:2177-84.
9. Lewinsky T, Zulawsky M. Small cell lung cancer survival: 3 Years as a minimum for predicting a favorable outcome. Lung cancer 2003;40: 203-13.
10. Al-Ajam M, Seymour A, Mooty M, Leaf A. Ten years of disease-free survival between two diagnoses of small-cell lung cancer: A case report and a literature review. Med Oncol 2005;22:89-98.
11. Niiranen A. Long-term survival in small cell carcinoma of the lung. Eur J Cancer Clin Oncol 1988;24:749-752.
12. Brigham BA, Bunn PA, Minna JD, Cohen MH, Ihde DC, Shacheny SE. Growth rates of small cell bronchogenic carcinomas. Cancer 1978;42: 2880-6.
13. Kitamoto Y, Hayakawa K, Mitsuhashi N, Tsuchiya S, Saito R. Redevelopment of small cell lung cancer after a long disease-free period: A case report. Jpn J Clin Oncol 2002;32:30-2.
14. Lassen U, Østerlind K, Hansen M, Donbernousky P, Bergman B, Hansen HH. Long-term survival in small-cell lung cancer. Post-treatment characteristics in patients surviving 5 to 18+ years - an analysis of 1714 consecutive patients. J Clin Oncol 1995;13:1215-20.
15. Johnson BE, Linnoila RI, Williams JP, Venzon DJ, Okunieff P, Anderson GB, et al. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol 1995;13:101-11.
16. Wistuba I, Berry J, Behrens C, Maitra A, Shivapurkar N, Milchgrub S, et al. Molecular changes in the bronchial epithelium of patients with small cell lung cancer. Clin Cancer Res 2000;6:2604-10.
17. Tucker MA, Murray N, Shaw EG, Ettinger DS, Marbry M, Huber MH, et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. J Natl Cancer Inst 1997;89: 1782-8.
18. Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993;119:383-90.
19. Batist G, Ihde DC, Zabell A, Lichter AS, Veach SR, Cohen MH, et al. Small-cell carcinoma of lung: Reinduction therapy after late relapse. Ann Intern Med 1983;98: 472-4.
20. Sekine I, Nishiwaki Y, Kakinuma R, Kubota K, Hojo F, Matsumoto T, et al. Late recurrence of small cell lung cancer, treatment and out come. Oncol 1996;53: 318-21.